Both in Pharmaceuticals
NewAmsterdam Pharma Company N.V vs Precigen
Over the past year NAMS returned −13.5% and PGEN returned +121.8%; their daily moves had a correlation of 0.28.
NAMS −13.5% PGEN +121.8%Growth of $1, one year, split-adjusted
| Metric | NAMS | PGEN |
|---|---|---|
| Price | $23.81 | $8.05 |
| Market cap | $2.85B | $2.88B |
| Today | +0.98% | +3.07% |
| 1 month | −8.1% | +15.8% |
| 6 months | −18.8% | +147.7% |
| Year to date | −32.1% | +92.6% |
| 1 year | −16.5% | +129.3% |
| Revenue growth (YoY) | −80.7% | +6322.7% |
| Gross margin | 100.0% | 94.9% |
| Net margin | −1732.9% | 36.5% |
| P/E (TTM) | — | — |
| Price / sales | 399.7× | 33.6× |
| Net cash | $633.9M | -$55.7M |
| Dividend yield | — | — |
| Volatility (60d) | 53.2% | 54.5% |
| Short % of float | 23.3% | 23.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).